When we evaluated the effect of TB treatment on the activation profile of ESAT-6/CFP-10-stimulated CD4+ T-cells, we observed significant declines in the proportion of CD38+HLA-DR+ CD4+ T-cells of HIV−TB (p = 0.001, Supplementary Figure S4A). This evidence concerns the gene CD38 and tuberculosis.